Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04374071 · ClinicalTrials.gov registry record
Early Short Course Corticosteroids in COVID-19
A clinical trial of COVID and Pneumonia, Viral, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT04374071: Completed study of COVID and Pneumonia, Viral, sponsored by Henry Ford Health System.
NCT04374071 is a study of COVID and Pneumonia, Viral that has completed, run by Henry Ford Health System. The registered enrollment target is 250 participants, below the 2,585-participant average among 14 other COVID trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04374071, a study of COVID and Pneumonia, Viral, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators intend to study the role of early use of methylprednisolone in the hospitalized patients with a diagnosis of COVID-19 pneumonia.
Primary Outcome
Number of patients transferred to ICU is each of the groups
Conditions Studied
Interventions
- DRUG Methylprednisolone
Study Locations (1)
Michigan
- Henry Ford Hospital - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2020-03-12 |
| Est. Completion | 2020-04-30 |
What the finished NCT04374071 record still lists
NCT04374071 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 2,585-participant average among 14 other COVID trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with COVID appearing as the primary indexed condition, and to 1 intervention - of which Methylprednisolone is the first listed.
NCT04374071 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04374071 about?
NCT04374071 is a clinical study titled "Early Short Course Corticosteroids in COVID-19". The investigators intend to study the role of early use of methylprednisolone in the hospitalized patients with a diagnosis of COVID-19 pneumonia.
What is the current status of trial NCT04374071?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2020-03-12. Estimated completion is 2020-04-30.
What conditions does trial NCT04374071 study?
This clinical trial studies the following conditions: COVID, Pneumonia, Viral.
What interventions are being tested in trial NCT04374071?
The interventions under investigation include: Methylprednisolone (DRUG).
Who is sponsoring clinical trial NCT04374071?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04374071 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04374071's enrollment target sits among peer trials
250 9th of 14 higher than 5 of 14 other COVID trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
RECRUITING
-
Long-term Impact of Infection With Novel Coronavirus (COVID-19)
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
RECRUITING · NA
-
A Study to Explore the Role of Gut Flora in COVID-19 Infection
RECRUITING
-
COVID-19 Biorepository
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI